<DOC>
	<DOCNO>NCT02201134</DOCNO>
	<brief_summary>Studying feasibility initial sedation inhalated sevoflurane therapeutic hypothermia cardiac arrest resuscitate patient .</brief_summary>
	<brief_title>SEVOflurane Inhalation CARdiac Arrest Resuscitated Patients Treated With Therapeutic Hypothermia</brief_title>
	<detailed_description>Prospective clinical study ICU ventilate patient sedate sevoflurane use Mirus® Anaconda® , establish feasibility initial sedation patient resuscitate cardiac arrest treat therapeutic hypothermia .</detailed_description>
	<mesh_term>Heart Arrest</mesh_term>
	<mesh_term>Hypothermia</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>Adult patient ventilate require therapeutic hypothermia ICU Stable respiratory hemodynamic condition Epinephrine norepinephrine infusion rate &lt; 1,5 g/kg/min Consent patient family Arterial line Patients resuscitate cardiac arrest No Flow &lt; 10 min Low Flow &lt; 20 min Neutropenia &lt; 1 G/L Post traumatic cardiac arrest Contraindication halogenated anesthesics Extra corporeal life support intra aortic balloon pump Pregnant woman Hemodynamic instability Brain death define disappearance brain stem reflex</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Cardiac arrest</keyword>
	<keyword>Therapeutic hypothermia</keyword>
	<keyword>Sevoflurane</keyword>
	<keyword>Sedation</keyword>
	<keyword>Patient resuscitate cardiac arrest</keyword>
	<keyword>Requiring sedation</keyword>
	<keyword>Adult patient</keyword>
	<keyword>Patient cover french health care system</keyword>
</DOC>